CSF LYMPHOCYTE COUNT INCREASED

CSF LYMPHOCYTE COUNT INCREASED was reported 62 times

These drug classes are most commonly taken by patients reporting CSF LYMPHOCYTE COUNT INCREASED:

# Drug Count
0 Corticosteroid [EPC] 10
1 Alkylating Drug [EPC] 6
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 6
3 Benzodiazepine [EPC] 5
4 Atypical Antipsychotic [EPC] 3
5 CD20-directed Cytolytic Antibody [EPC] 3
6 Folate Analog Metabolic Inhibitor [EPC] 3
7 Nonsteroidal Anti-inflammatory Drug [EPC] 3
8 Aminosalicylate [EPC] 2
9 Androgen Receptor Inhibitor [EPC] 2
10 Antisense Oligonucleotide [EPC] 2
11 Calcineurin Inhibitor Immunosuppressant [EPC] 2
12 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2
13 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
14 Integrin Receptor Antagonist [EPC] 2
15 Mood Stabilizer [EPC] 2
16 Nucleoside Metabolic Inhibitor [EPC] 2
17 Platinum-based Drug [EPC] 2
18 Purine Antimetabolite [EPC] 2
19 Acetylcholine Release Inhibitor [EPC] 1
20 Anti-epileptic Agent [EPC] 1
21 Anticholinergic [EPC] 1
22 Antimalarial [EPC] 1
23 Antimycobacterial [EPC] 1
24 Antiprotozoal [EPC] 1
25 Azole Antifungal [EPC] 1
26 CTLA-4-directed Blocking Antibody [EPC] 1
27 Dietary Cholesterol Absorption Inhibitor [EPC] 1
28 Dihydropyridine Calcium Channel Blocker [EPC] 1
29 HMG-CoA Reductase Inhibitor [EPC] 1
30 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
31 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
32 Histamine-2 Receptor Antagonist [EPC] 1
33 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
34 Insulin Analog [EPC] 1
35 Interferon beta [EPC] 1
36 Kinase Inhibitor [EPC] 1
37 Leukocyte Growth Factor [EPC] 1
38 Microtubule Inhibitor [EPC] 1
39 Neuromuscular Blocker [EPC] 1
40 Non-Standardized Food Allergenic Extract [EPC] 1
41 Platelet Aggregation Inhibitor [EPC] 1
42 Proteasome Inhibitor [EPC] 1
43 Proton Pump Inhibitor [EPC] 1
44 Serotonin-3 Receptor Antagonist [EPC] 1
45 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1
46 Survival Motor Neuron-2-directed RNA Interaction [EPC] 1
47 Sympathomimetic-like Agent [EPC] 1
48 Tetracycline-class Drug [EPC] 1
49 Tumor Necrosis Factor Blocker [EPC] 1
50 Vitamin B12 [EPC] 1
51 Vitamin C [EPC] 1
52 Vitamin D [EPC] 1
53 beta-Adrenergic Blocker [EPC] 1
54 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1